Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04655118
Title Study of TL-895 in Subjects With Myelofibrosis or Indolent Systemic Mastocytosis
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Telios Pharma, Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | POL | ITA | HUN | FRA | ESP | DEU | BRA | BGR | BEL | AUS


No variant requirements are available.